ChipCare is a Toronto-based pre-revenue company, developing a point-of-care platform which will have the unique capability of providing a differential diagnosis for Sexually Transmitted Infections (STIs). STIs represent more than a $1 billion market with a CAGR of 10%.

This diagnosis will inform appropriate prescription medication that can be dispensed to the patient upon completion.

We intend to place the platform in national pharmacy and retail store chain clinics and Planned Parenthood, among others.

Chip Care logo



Event details

Date: September 14 - 16, 2020

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


16 in total